Search - tctmd.com

Displaying 61 - 80 of 259

Sort: Relevancy | Date

FDA Approves Dual-Energy System for AF Ablation

News Daily News

FDA Approves Dual-Energy System for AF Ablation

October 28, 2024

LAAO Outcomes Similar Regardless of Operator’s Specialty

News Conference News TCT 2024

LAAO Outcomes Similar Regardless of Operator’s Specialty

October 27, 2024

AHA Statement Outlines Cardiac Contributions to Brain Health

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

October 11, 2024

TCTMD’s Top 10 Most Popular Stories for September 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2024

October 01, 2024

Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial

News Daily News

Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial

September 30, 2024

Streamlined European AF Guidelines Emphasize ‘Whole’ Patient

News Conference News ESC 2024

Streamlined European AF Guidelines Emphasize ‘Whole’ Patient

September 06, 2024

STEEER-AF: Educating Healthcare Workers Improves Adherence to Guidelines

News Conference News ESC 2024

STEEER-AF: Educating Healthcare Workers Improves Adherence to Guidelines

September 06, 2024

SHAM-PVI Catheter Ablation Improves Objective Measure of AF Burden

News Conference News ESC 2024

SHAM-PVI: Catheter Ablation Improves Objective Measure of AF Burden

September 02, 2024

The SHAM-PVI Study: A randomized sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation

Presentation ESC 2024

The SHAM-PVI Study: A randomized sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation

Presenter: Rick Veasey

September 02, 2024

The efficacy of low-voltage-area ablation in patients with persistent atrial fibrillation: Results from a SUPPRESS-AF trial

Presentation ESC 2024

The efficacy of low-voltage-area ablation in patients with persistent atrial fibrillation: Results from a SUPPRESS-AF trial

Presenter: Masaharu Masuda

September 02, 2024

September 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

September 01, 2024

Stroke prevention & rhythm control Therapy: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomised trial in patients with Atrial Fibrillation

Presentation ESC 2024

Stroke prevention & rhythm control Therapy: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomised trial in patients with Atrial Fibrillation

Presenter: Dipak Kotecha

September 01, 2024

Long-term Digoxin Use Linked to VT/VF Risk in HF Patients

News Daily News

Long-term Digoxin Use Linked to VT/VF Risk in HF Patients

June 11, 2024

June 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

June 01, 2024

Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus

News Conference News HRS 2024

Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus

Michael O'Riordan

May 23, 2024

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

News Conference News HRS 2024

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

May 23, 2024

Concomitant AF Procedures During Non-Mitral Surgery Less Likely in Women

News Conference News

Concomitant AF Procedures During Non-Mitral Surgery Less Likely in Women

Yael L. Maxwell

May 09, 2024

News Industry News

Biosense Webster Launches New Version of CARTO™ 3 Electro-Anatomical Mapping System

May 08, 2024

May 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

May 01, 2024

AF Patients Under Age 65 Have High Risk Factor Burden, More Adverse Outcomes

News Daily News

AF Patients Under Age 65 Have High Risk Factor Burden, More Adverse Outcomes

April 26, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.